Sang Jae Rhee (Sang-Jae Rhee)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 9

Top Topics

Left Ventricular

Acute Myocardial Infarction

Clinical Practice

Top Venues

Journal of clinical medicine

Korean circulation journal

Journal of cardiovascular imaging

This page only lists publications with an associated author ORCID identifier.

Publications

Kye-Hwan Kim, Moojun Kim, Chang-Ok Seo, Hangyul Kim, Hye Ree Kim, Min Gyu Kang, Jin-Sin Koh, Jeong Rang Park, Rock Beum Kim, Dong Ryeol Ryu, Jang-Hoon Lee, Moo-Hyun Kim, Tae-Jin Youn, Dae Woo Hyun, Shin-Jae Kim, Sang Jae Rhee, Sang-Don Park, Young Joon Hong, Jae-Geun Lee, Pil Sang Song, Sang Min Kim, Seung Jin Lee, Jin-Yong Hwang
Clinical Impact of Self-Recognition of Recurrent Acute Myocardial Infarction: From KRMI-RCC. Journal of clinical medicine 13 (16) (2024)
Kye-Hwan Kim, Moojun Kim, Chang-Ok Seo, Hangyul Kim, Hye Ree Kim, Min Gyu Kang, Jin-Sin Koh, Jeong Rang Park, Rock Beum Kim, Dong Ryeol Ryu, Jang-Hoon Lee, Moo-Hyun Kim, Tae-Jin Youn, Dae Woo Hyun, Shin-Jae Kim, Sang Jae Rhee, Sang-Don Park, Young Joon Hong, Jae-Geun Lee, Pil Sang Song, Sang Min Kim, Seung Jin Lee, Jin-Yong Hwang
Clinical Impact of Self-Recognition of Recurrent Acute Myocardial Infarction: From KRMI-RCC. Journal of clinical medicine 13 (16) (2024)
Donghyun Kim, Gyuho Jang, Jaetaek Hwang, Xiaofan Wei, Hyunsoo Kim, Jinbae Son, Sang Jae Rhee, Kyeong Ho Yun, Seok-Kyu Oh, Chang-Myung Oh, Raekil Park
Combined Therapy of Low-Dose Angiotensin Receptor-Neprilysin Inhibitor and Sodium-Glucose Cotransporter-2 Inhibitor Prevents Doxorubicin-Induced Cardiac Dysfunction in Rodent Model with Minimal Adverse Effects. Pharmaceutics 14 (12) (2022)
Donghyun Kim, Gyuho Jang, Jaetaek Hwang, Xiaofan Wei, Hyunsoo Kim, Jinbae Son, Sang Jae Rhee, Kyeong Ho Yun, Seok-Kyu Oh, Chang-Myung Oh, Raekil Park
Combined Therapy of Low-Dose Angiotensin Receptor-Neprilysin Inhibitor and Sodium-Glucose Cotransporter-2 Inhibitor Prevents Doxorubicin-Induced Cardiac Dysfunction in Rodent Model with Minimal Adverse Effects. Pharmaceutics 14 (12) (2022)
Donghyun Kim, Gyuho Jang, Jaetaek Hwang, Xiaofan Wei, Hyunsoo Kim, Jinbae Son, Sang Jae Rhee, Kyeong Ho Yun, Seok-Kyu Oh, Chang-Myung Oh, Raekil Park
Combined Therapy of Low-Dose Angiotensin Receptor-Neprilysin Inhibitor and Sodium-Glucose Cotransporter-2 Inhibitor Prevents Doxorubicin-Induced Cardiac Dysfunction in Rodent Model with Minimal Adverse Effects. Pharmaceutics 14 (12) (2022)
Donghyun Kim, Gyuho Jang, Jaetaek Hwang, Xiaofan Wei, Hyunsoo Kim, Jinbae Son, Sang Jae Rhee, Kyeong Ho Yun, Seok-Kyu Oh, Chang-Myung Oh, Raekil Park
Combined Therapy of Low-Dose Angiotensin Receptor-Neprilysin Inhibitor and Sodium-Glucose Cotransporter-2 Inhibitor Prevents Doxorubicin-Induced Cardiac Dysfunction in Rodent Model with Minimal Adverse Effects. Pharmaceutics 14 (12) (2022)
Hyung Yoon Kim, Sung-A Chang, Kye Hun Kim, Jae-Young Kim, Woo-Keun Seo, Hyungseop Kim, Jeong Sook Seo, Sung Hee Shin, Sang Jae Rhee, Sun Hwa Lee, Jung Sun Cho, null null
Epidemiology of Venous Thromboembolism and Treatment Pattern of Oral Anticoagulation in Korea, 2009-2016: a Nationwide Study Based on the National Health Insurance Service Database. Journal of cardiovascular imaging 29 (3) (2021)
Kyeong Ho Yun, Jae Young Cho, Sang Jae Rhee, Seok Kyu Oh
Temporal Variability of Platelet Reactivity in Patients Treated with Clopidogrel or Ticagrelor. Korean circulation journal 49 (11) (2019)
Kyeong Ho Yun, Sang Jae Rhee, Jum Suk Ko
Comparison of the Infarct Size between the Loading of Ticagrelor and Clopidogrel in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Korean circulation journal 47 (5) (2017)